SurGenTec announced the first implantations and 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its OsteoFlo HydroPutty Synthetic Bone Graft. OsteoFlo HydroPutty represents...
Johnson & Johnson announced it has successfully completed the acquisition of Ambrx Biopharma, Inc., in an all-cash merger transaction for a total equity value of approximately...
BIOBOT Surgical announced a significant milestone in their journey: the successful closure of their Series B funding round, securing an impressive S$24 MM (US$ 18 MM)....
Myomo, Inc. announced financial results for the three months and year ended December 31, 2023. Financial and operational highlights for the fourth quarter of 2023 include...
Rakuten Medical, Inc. announced the completion of a $119 million Series E preferred stock financing, including $45 million in new capital and the conversion of $74...
Evogene Ltd. announced its financial results for the fourth quarter and full-year period ending December 31, 2023. Ofer Haviv, Evogene’s President, and Chief Executive Officer, stated,...
Alafair Biosciences, Inc., announced business results and highlights for 2023. Alafair’s flagship product, VersaWrap®, is an FDA-cleared medical device implant (not tissue) comprising hyaluronic acid (HA)...
bioAffinity Technologies, Inc. announced it has entered into a securities purchase agreement with institutional investors for the purchase and sale of 1,600,000 shares of common stock...
PruittHealth Medical Supply announced its acquisition of Allied Health Resources (AHR). All Allied Health Resources technicians and customer service partners have been retained by PruittHealth Medical...
Sionna Therapeutics announced the closing of a $182 million Series C financing to support the clinical development of first-in-class small molecules designed to fully restore the...
BrainCheck, Inc. announced a $15 million new financing round, led by Next Coast Ventures, S3 Ventures, and UPMC Enterprises, the innovation, commercialization, and venture capital arm...
OrthoPediatrics Corp. announced its financial results for the fourth quarter and full year ended December 31, 2023. “2023 was another strong year for OrthoPediatrics as we...
Avid Bioservices, Inc. announced the pricing of $160 million aggregate principal amount of 7.00% Convertible Senior Notes due 2029 (the “2029 Notes”). In connection with the...
NeueHealth, Inc. reported financial results for its fourth quarter and full year ended December 31, 2023. “We achieved significant milestones as a company this past year,...
Nalu Medical, Inc. announced the closing of an incremental $20M in equity financing from new investor B Capital, bringing the total Series E round of equity...
Copyright © 2024 Medical Buyer